Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites

Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites

US Patent 8277806 · Granted Oct 2, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of the application of antibodies for immunostimulation together with2020
Combination of the application of antibodies for immunostimulation together with2018
Initial relative lymphocyte count as predictive biomarker2017
Vaccine preparation containing trifunctional antibodies with antigen immunogenic2017
Removal of tumor cells from intraoperative autologous blood salvage2017
Destruction of tumor cells by trifunctional bispecific antibodies with low to me2015
Combination of the application of antibodies for immunostimulation together with2014
Intraoperative trifunctional antibody application for prophylaxis of intraperito2014
Method of treating tumor growth and metastasis by using trifunctional antibodies2011
Method for ex vivo immunization using heterologous intact bispecific and/or tris2011
Method for ex vivo immunization using heterologous intact bispecific and/or tris2006
Time-staggered utilization of tumor cells in combination with intact antibodies 2006